Literature DB >> 20847403

Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease.

Laura D Baker1, Laura L Frank, Karen Foster-Schubert, Pattie S Green, Charles W Wilkinson, Anne McTiernan, Brenna A Cholerton, Stephen R Plymate, Mark A Fishel, G Stennis Watson, Glen E Duncan, Pankaj D Mehta, Suzanne Craft.   

Abstract

Impaired glucose regulation is a defining characteristic of type 2 diabetes mellitus (T2DM) pathology and has been linked to increased risk of cognitive impairment and dementia. Although the benefits of aerobic exercise for physical health are well-documented, exercise effects on cognition have not been examined for older adults with poor glucose regulation associated with prediabetes and early T2DM. Using a randomized controlled design, twenty-eight adults (57-83 y old) meeting 2-h tolerance test criteria for glucose intolerance completed 6 months of aerobic exercise or stretching, which served as the control. The primary cognitive outcomes included measures of executive function (Trails B, Task Switching, Stroop, Self-ordered Pointing Test, and Verbal Fluency). Other outcomes included memory performance (Story Recall, List Learning), measures of cardiorespiratory fitness obtained via maximal-graded exercise treadmill test, glucose disposal during hyperinsulinemic-euglycemic clamp, body fat, and fasting plasma levels of insulin, cortisol, brain-derived neurotrophic factor, insulin-like growth factor-1, amyloid-β (Aβ40 and Aβ42). Six months of aerobic exercise improved executive function (MANCOVA, p=0.04), cardiorespiratory fitness (MANOVA, p=0.03), and insulin sensitivity (p=0.05). Across all subjects, 6-month changes in cardiorespiratory fitness and insulin sensitivity were positively correlated (p=0.01). For Aβ42, plasma levels tended to decrease for the aerobic group relative to controls (p=0.07). The results of our study using rigorous controlled methodology suggest a cognition-enhancing effect of aerobic exercise for older glucose intolerant adults. Although replication in a larger sample is needed, our findings potentially have important therapeutic implications for a growing number of adults at increased risk of cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20847403      PMCID: PMC3049111          DOI: 10.3233/JAD-2010-100768

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  69 in total

Review 1.  Exercise builds brain health: key roles of growth factor cascades and inflammation.

Authors:  Carl W Cotman; Nicole C Berchtold; Lori-Ann Christie
Journal:  Trends Neurosci       Date:  2007-08-31       Impact factor: 13.837

2.  Level of executive function influences verbal memory in amnestic mild cognitive impairment and predicts prefrontal and posterior cingulate thickness.

Authors:  Yu-Ling Chang; Mark W Jacobson; Christine Fennema-Notestine; Donald J Hagler; Robin G Jennings; Anders M Dale; Linda K McEvoy
Journal:  Cereb Cortex       Date:  2009-09-23       Impact factor: 5.357

3.  Effect of age and glucoregulation on cognitive performance.

Authors:  Claude Messier; Maria Tsiakas; Michèle Gagnon; Alain Desrochers
Journal:  J Clin Exp Neuropsychol       Date:  2010-03-05       Impact factor: 2.475

Review 4.  Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention?

Authors:  José A Luchsinger
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors.

Authors:  C Messier; M Gagnon
Journal:  Diabetologia       Date:  2009-09-25       Impact factor: 10.122

Review 6.  Cognition and diabetes: a lifespan perspective.

Authors:  Geert Jan Biessels; Ian J Deary; Christopher M Ryan
Journal:  Lancet Neurol       Date:  2008-02       Impact factor: 44.182

7.  Neuropsychological measures in normal individuals that predict subsequent cognitive decline.

Authors:  Deborah Blacker; Hang Lee; Alona Muzikansky; Emily C Martin; Rudolph Tanzi; John J McArdle; Mark Moss; Marilyn Albert
Journal:  Arch Neurol       Date:  2007-06

8.  Effects of aerobic exercise on mild cognitive impairment: a controlled trial.

Authors:  Laura D Baker; Laura L Frank; Karen Foster-Schubert; Pattie S Green; Charles W Wilkinson; Anne McTiernan; Stephen R Plymate; Mark A Fishel; G Stennis Watson; Brenna A Cholerton; Glen E Duncan; Pankaj D Mehta; Suzanne Craft
Journal:  Arch Neurol       Date:  2010-01

9.  Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype.

Authors:  Edward G Stopa; Parag Butala; Stephen Salloway; Conrad E Johanson; Liliana Gonzalez; Rosemarie Tavares; Virginia Hovanesian; Christine M Hulette; Michael P Vitek; Ronald A Cohen
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

10.  Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.

Authors:  S M Manschot; G J Biessels; H de Valk; A Algra; G E H M Rutten; J van der Grond; L J Kappelle
Journal:  Diabetologia       Date:  2007-09-02       Impact factor: 10.122

View more
  84 in total

1.  Physical activity for the prevention of cognitive decline: current evidence from observational and controlled studies.

Authors:  M D Denkinger; T Nikolaus; C Denkinger; A Lukas
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

2.  Glucose regulation and cognitive function after bariatric surgery.

Authors:  Rachel Galioto; Michael L Alosco; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ronald Cohen; Ross D Crosby; James E Mitchell; John Gunstad
Journal:  J Clin Exp Neuropsychol       Date:  2015-04-15       Impact factor: 2.475

Review 3.  Obesity, insulin resistance, and Alzheimer's disease.

Authors:  Kerry L Hildreth; Rachael E Van Pelt; Robert S Schwartz
Journal:  Obesity (Silver Spring)       Date:  2012-02-07       Impact factor: 5.002

Review 4.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

Review 5.  Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.

Authors:  Almudena Areosa Sastre; Robin Wm Vernooij; Magali González-Colaço Harmand; Gabriel Martínez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-15

6.  Physical exercise promotes memory capability by enhancing hippocampal mitochondrial functions and inhibiting apoptosis in obesity-induced insulin resistance by high fat diet.

Authors:  Hye-Sang Park; Han-Sam Cho; Tae-Woon Kim
Journal:  Metab Brain Dis       Date:  2017-11-29       Impact factor: 3.584

7.  Long-term Impact of Weight Loss Intervention on Changes in Cognitive Function: Exploratory Analyses from the Action for Health in Diabetes Randomized Controlled Clinical Trial.

Authors:  Mark A Espeland; Owen Carmichael; Kathleen Hayden; Rebecca H Neiberg; Anne B Newman; Jeffery N Keller; Thomas A Wadden; Stephen R Rapp; James O Hill; Edward S Horton; Karen C Johnson; Lynne Wagenknecht; Rena R Wing
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-14       Impact factor: 6.053

8.  Multimodal physical activity increases brain-derived neurotrophic factor levels and improves cognition in institutionalized older women.

Authors:  Kelem Vedovelli; Bruno Lima Giacobbo; Márcio Silveira Corrêa; Andréa Wieck; Irani Iracema de Lima Argimon; Elke Bromberg
Journal:  Geroscience       Date:  2017-07-13       Impact factor: 7.713

Review 9.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

10.  Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits.

Authors:  Jim R Fadel; Lawrence P Reagan
Journal:  Curr Opin Behav Sci       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.